REFERENCES
- Modell B., Berdoukas V. The Clinical Approach to Thalassemia. Grune & Stratton:, New YorkNY, USA 1984
- Cappellini N., Cohen A., Eleftheriou A., Piga A., Porter J. Thalassemia Intermedia. Guidelines for the Clinical Management of Thalassemia. Thalassemia International Federation:, NicosiaCyprus 2000; 74–81
- Michaeli J., Mittelman M., Grisaru D., Rachmilewitz A. E. Thromboembolic Complications in β-Thalassemia Major. Acta Haematol. 1992; 82: 71–74
- Pignatti C. B., Carnelli V., Caruso V. Thromboembolic Events in β-Thalassemia Major: An Italian Multicentre Study. Acta Haematol. 1998; 99: 76–79
- Shmuel G., Cappellini D. M., Goldfarb A., Ciceri L., Fiorelli G., Rachmilewitz A. E. Pulmonary Thromboembolism in Thalassemia Intermedia Patients. Haematologica 1999; 84: 959–960
- Ciceri L., Amat M., Cappellini D. M., Fiorelli G. A Case of Pulmonary Thromboembolism in Thalassemia Intermedia: Are These Patients at Risk for Thrombotic Events?. Ann. Ital. Med. Int. 2000; 3: 218–220
- Sonakul D., Fucharoen S. Pulmonary Thromboembolism in Thalassemia Patients. SE Asian J. Trop. Med. Pub. Hlth. 1992; 23: 25–28
- Aessopos A., Stamatelos G., Skoumas V., Vassilopoulous G., Mantzourani M., Loukopoulos D. Pulmonary Hypertension and Right Heart Failure in Patients with β-Thalassemia Intermedia. Chest 1995; 107: 50–53
- Aessopos A., Farmakis D., Karagiorga M., Voskariodu E., Loutradi A., Hatziliami A., Joussef J., Rombos J., Loukopoulos D. Cardiac Involvement in Thalassemia Intermedia: A Multicenter Study. Blood 2001; 97: 3411–3416
- Cappellini D. M., Coppola R., Robbiolo L., Graziadei G., Valentini M., Ariens S. R.A., Fiorelli G., Mannucci M. P. Procoagulant Activity of Erythrocytes in Thalassemia Intermedia. Blood 1996; 88 (suppl.1): 38
- O'Driscoll A., Mackie J. I., Porter B. J., Machin J. S. Low Plasma Heparin Cofactor Levels in Thalassemia Syndromes are Corrected by Chronic Blood Transfusion. Br. J. Haematol. 1995; 90: 65–70
- Borenstain-Ben Yashar V., Barenholz Y., Hy-Am E., Rachmilewitz A. E., Eldor A. Phosphatidylserine in the Outer Leaflet of Red Blood Cells from β-Thalassemia Patients may Explain the Chronic Hypercoagulable State and Thrombotic Episodes. Am. J. Hematol. 1993; 44: 63–65
- Helley D., Eldor A., Girot R., Ducrocq R., Guillin C. M., Bezaud A. Increased Procoagulant Activity of Red Blood Cells from Patients with Homozygous Sickle Cell Disease and β-Thalassemia. Thromb. Haemost. 1996; 76: 322–327
- Eldor A., Lellouche F., Goldfarb A. In Vivo Platelet Activation in β-Thalassemia Major Reflected by Increased Platelet-Thromboxane Urinary Metabolites. Blood 1991; 77: 1749–1753
- Cappellini D. M., Robbiolo L., Bottasso M. B., Coppola R., Fiorelli G., Mannucci P. A. Venous Thromboembolism and Hypercoagulability in Splenectomised Patients with Thalassaemia Intermedia. Br. J. Haematol. 2000; 111(2)467–473